Network of community-based oncology investigative sites conducting complex Phase 1 clinical trials with standardized, centralized operations for efficiency, high-quality data, and faster study start-up. Patient-centric model connecting pharmaceutical, biotech, and CRO partners with local patients to expand access to experimental cancer therapies and generate reliable outcomes.